These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 35403343)

  • 1. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
    Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
    Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
    Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating
    Zhu C; Cheng Y; Yu Y; Zhang Y; Ren G
    Biomol Biomed; 2024 Sep; 24(5):1244-1257. PubMed ID: 38577917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
    Li J; Momen-Heravi F; Wu X; He K
    Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The m
    Romanowska K; Rawłuszko-Wieczorek AA; Marczak Ł; Kosińska A; Suchorska WM; Golusiński W
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
    Liang J; Cai H; Hou C; Song F; Jiang Y; Wang Z; Qiu D; Zhu Y; Wang F; Yu D; Hou J
    Clin Sci (Lond); 2023 Sep; 137(17):1373-1389. PubMed ID: 37615536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles and mechanisms of m
    Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
    [No Abstract]   [Full Text] [Related]  

  • 11. METTL3-mediated ALDH m
    Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
    Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
    Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
    Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma.
    Rong M; Zhang M; Dong F; Wu K; Cai B; Niu J; Yang L; Li Z; Lu HY
    Cancer Cell Int; 2024 Mar; 24(1):113. PubMed ID: 38528591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways.
    Zhao K; Chen L; Xie Y; Ren N; Li J; Zhai X; Zheng S; Liu K; Wang C; Qiu Q; Peng X; Wang W; Liu J; Che Q; Fan J; Hu H; Liu M
    Cancer Lett; 2024 Apr; 587():216735. PubMed ID: 38369001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
    Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
    Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5.
    Jiang Y; Guo H; Tong T; Xie F; Qin X; Wang X; Chen W; Zhang J
    Mol Ther; 2022 Jan; 30(1):448-467. PubMed ID: 34111560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1.
    Zhang Y; Chen L; Wu X; Sun Z; Wang F; Wang B; Dong P
    Int J Gen Med; 2021; 14():8785-8795. PubMed ID: 34853532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.